Millennium Management’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $481K | Buy |
90,708
+51,143
| +129% | +$271K | ﹤0.01% | 3388 |
|
|
2025
Q1 | $175K | Buy |
+39,565
| New | +$175K | ﹤0.01% | 3672 |
|
|
2024
Q4 | – | Sell |
-2,003
| Closed | -$29K | – | 4517 |
|
|
2024
Q3 | $29K | Buy |
+2,003
| New | +$29K | ﹤0.01% | 3965 |
|
|
2023
Q4 | – | Sell |
-2,832
| Closed | -$110K | – | 4574 |
|
|
2023
Q3 | $110K | Sell |
2,832
-23,229
| -89% | -$902K | ﹤0.01% | 3754 |
|
|
2023
Q2 | $1.5M | Buy |
26,061
+8,240
| +46% | +$475K | ﹤0.01% | 2688 |
|
|
2023
Q1 | $1.16M | Sell |
17,821
-2,724
| -13% | -$177K | ﹤0.01% | 2936 |
|
|
2022
Q4 | $565K | Buy |
20,545
+13,138
| +177% | +$361K | ﹤0.01% | 3552 |
|
|
2022
Q3 | $216K | Sell |
7,407
-5,966
| -45% | -$174K | ﹤0.01% | 4400 |
|
|
2022
Q2 | $257K | Buy |
13,373
+3,602
| +37% | +$69.2K | ﹤0.01% | 4336 |
|
|
2022
Q1 | $792K | Buy |
9,771
+349
| +4% | +$28.3K | ﹤0.01% | 3756 |
|
|
2021
Q4 | $863K | Buy |
9,422
+7,759
| +467% | +$711K | ﹤0.01% | 3596 |
|
|
2021
Q3 | $208K | Sell |
1,663
-30,292
| -95% | -$3.79M | ﹤0.01% | 4711 |
|
|
2021
Q2 | $3.61M | Buy |
31,955
+28,613
| +856% | +$3.23M | ﹤0.01% | 2499 |
|
|
2021
Q1 | $506K | Sell |
3,342
-30,190
| -90% | -$4.57M | ﹤0.01% | 3658 |
|
|
2020
Q4 | $3.86M | Sell |
33,532
-2,765
| -8% | -$318K | ﹤0.01% | 2088 |
|
|
2020
Q3 | $2.81K | Buy |
+36,297
| New | +$2.81K | ﹤0.01% | 1817 |
|
|
2018
Q3 | – | Sell |
-2,575
| Closed | -$508K | – | 3799 |
|
|
2018
Q2 | $508K | Buy |
+2,575
| New | +$508K | ﹤0.01% | 2800 |
|